Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

334
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
334
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GatedGeoGO:Multi-Modal Geometry-Aware Network with Gated Fusion and GO Semantic Attention for Protein Function Prediction.

Journal of chemical information and modeling·2026
Same author

Comprehensive Review of Contrastive and Generative Self-Supervised Learning for Small Molecular Representation.

Journal of chemical information and modeling·2026
Same author

Spatial and temporal evolution of land use carbon emission and carbon balance zoning: evidence from Xinjiang China.

Scientific reports·2025
Same author

Electromagnetic Wave Absorption Performance Regulation of Crystalline Nickelphthalocyanine Covalent Organic Frameworks via Ionothermal Synthesis Temperatures.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Task-Specific Activity Cliff Prediction Method Based on Transfer Learning and a Hyper Connection Graph Model.

Journal of chemical information and modeling·2025
Same author

Geometry-complete latent diffusion model for 3D molecule generation.

Bioinformatics (Oxford, England)·2025
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformatics·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformatics·2026
Same journal

SimMapNet: a Bayesian framework for gene regulatory network inference using gene ontology similarities as external hint.

BMC bioinformatics·2026
Same journal

Dual channel drug-drug interactions extraction based on cross attention.

BMC bioinformatics·2026
Same journal

FeSseqdb: a curated sequence-level database and interpretable machine learning framework for identifying iron-sulfur proteins.

BMC bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

MSH-DTI: multi-graph convolution with self-supervised embedding and heterogeneous aggregation for drug-target

Beiyi Zhang1, Dongjiang Niu1, Lianwei Zhang1

  • 1College of Computer Science and Technology, Qingdao University, Ningxia Road, Qingdao, 266071, Shandong, China.

BMC Bioinformatics
|August 23, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces MSH-DTI, a deep learning model for predicting drug-target interactions (DTI). MSH-DTI enhances feature extraction and integration, achieving superior performance in DTI prediction.

Keywords:
Attention mechanismDrug-target interactionGraph convolutional networkHeterogeneous interaction-enhanced feature fusion moduleSelf-supervised learning

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Related Experiment Videos

Last Updated: Jun 15, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Network pharmacology utilizes computational methods for drug-target interaction (DTI) prediction.
  • Existing DTI models face limitations due to restricted feature data and simplistic information integration from multiple networks.

Purpose of the Study:

  • To propose MSH-DTI, a novel deep learning model for robust DTI prediction.
  • To address limitations in feature extraction and heterogeneous information integration in DTI prediction.

Main Methods:

  • Utilizes self-supervised learning for comprehensive drug and target structure feature extraction.
  • Employs a Heterogeneous Interaction-enhanced Feature Fusion Module for multi-graph construction.
  • Applies graph convolutional networks and an attention mechanism for effective feature extraction and integration.

Main Results:

  • MSH-DTI achieved high performance with AUROC of 0.9620 and AUPR of 0.9605 on the DTINet dataset.
  • Outperformed existing DTI prediction models in experimental evaluations.
  • Demonstrated the model's ability to focus on critical features through an attention mechanism.

Conclusions:

  • MSH-DTI serves as an effective tool for discovering novel drug-target interactions.
  • The model's utility is further validated by successful case studies in predicting new DTIs.